a series of hybridoma cell lines which produce monoclonal antibodies ( mabs ) against recombinant human interleukin-2 ( ril-2 ) have been established by fusion of murine myeloma cell line p3-ns1-1-ag4-1 and spleen cells of balb/c mice which had been immunized with ril-2 .
C0026764
myeloma
C0218986
ril-2